Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies - Wikidata - wikimedia - TriplyDB

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies

http://www.wikidata.org/entity/Q36003071

about

The Role of Galectin-3 in the Kidneys Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade State of the Art: Newer biomarkers in heart failure Clinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive Treatment Serial galectin-3 and future cardiovascular disease in the general population.The next generation of therapeutics for chronic kidney disease Diagnostic and prognostic value of galectin-3, serum creatinine, and cystatin C in chronic kidney diseases.Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.Methods for the detection and serum depletion of porcine galectin-3.Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).Prospective Validation of a Screening Biomarker Approach Combining Amino-Terminal Pro-Brain Natriuretic Peptide With Galectin-3 Predicts Death and Cardiovascular Events in Asymptomatic Hemodialysis Patients.Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.Identification of Targets of Interleukin-13 and Signal Transducer and Activator of Transcription-6 (STAT6) Signaling in Polycystic Kidney Disease.Targeting Immunity in End-Stage Renal Disease.Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure.

P2860

Q26752754-5D522F27-24AE-4513-AA22-407B8C7295A0 Q26799443-987C456C-71AC-4F0C-8703-15E986BCDB9F Q27027899-BF77F64B-7C26-46D9-A84B-71CB29C7F914 Q33754895-FC29CCAF-D025-4E59-9080-6E95F72459F2 Q37580709-E6FB992A-9208-496A-96DD-EBE1B3373B76 Q38845590-F2A0ADD8-823A-41E6-8E71-02DBC159D929 Q39303610-3066D178-DB64-48B5-BF73-900BC3EC707E Q40060474-BC05E67A-0C8A-4184-9E4C-2225A7AA3A0A Q45992912-C4E33E96-A642-46D4-81EF-E5E95588C376 Q47329197-C97E0851-B348-40F7-A21E-77A0E2D6E373 Q48035139-EA4EE14E-CEC9-4CD6-BCEB-8377961E23EF Q48159180-CEB2767E-FC10-4EA9-9216-03729345AC12 Q50420556-695BD1B1-E55F-4D2F-B03C-34E0E0202D57 Q50872135-01C8FC2C-DEAB-48D5-9C18-284B4FEAC491 Q55230733-D5B1E5A7-6CB4-419D-AE7D-BDE05D26DEA1

P2860

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies

http://www.wikidata.org/entity/Q36003071

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies

@ast

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies

@en

type

label

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies

@ast

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies

@en

prefLabel

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies

@ast

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies

@en

P1433

Q36003071-8F121FFF-3B13-4014-863F-96DFF1FAAA1D

P1476

Q36003071-D7E084BE-B08A-47C0-A11B-008DB1FD1EE4

P2093

Q36003071-06F0211E-E8B4-4928-99F7-3338DE56E8A0

Q36003071-0BD93123-220A-4646-A6BE-E35CC450135C

Q36003071-1E544D79-BD69-42A7-8887-BD61B0114DB9

Q36003071-4B624F0A-707A-43A9-9424-B6139E6F66B2

Q36003071-6A1BCA81-ACB2-47A4-A193-DD1C051C900D

Q36003071-8CA0068B-8E19-40D2-8F86-4B13A8987775

Q36003071-931A129C-7087-461F-A786-717C65447801

Q36003071-A0968C49-99A0-42B3-A424-41389BF81F49

Q36003071-ADB4AF5E-C55C-4949-96C5-C4F631E45395

Q36003071-AF90E0B6-0DB3-4117-93C3-927898786C60

P2860

Q36003071-060FB0CE-8B7D-4256-B469-FEC09C8FC5BC

Q36003071-07E49F1A-93C2-4940-9F8A-87EA5EDFA4C8

Q36003071-0FBF8B2C-DEDF-4101-92AB-7A8DE360C7F8

Q36003071-139A6672-C05A-4410-9B4C-11B7589F7DF1

Q36003071-1488676A-3AA5-4A1C-BD10-8C1A6049FF40

Q36003071-1F08284A-48B6-41DF-954D-DAF12206C849

Q36003071-201DD282-8FCC-4EF1-90AB-34B2169664E8

Q36003071-20CAE18D-8A57-4FC7-8250-DB2B43A883DD

Q36003071-2BBB7582-2F3D-433B-885E-947510C825FF

Q36003071-3201DA4B-43CD-4DE5-A5BA-C9F34711F1EF

P304

Q36003071-E075A48D-3A9A-45EA-9B40-6795DE0ACFBE

P31

Q36003071-A7F10193-A805-493E-999D-089AB6425563

P356

Q36003071-4AE0DC3B-75C7-49EA-97D7-F49C265CD0FA

P433

Q36003071-36A85293-12B9-4A23-96D2-575AAC60E6EB

P478

Q36003071-19628095-1565-4EEC-9C6E-29B011CEA032

P50

Q36003071-2269F8BB-8687-4F6E-AED5-A23E30A798F6

Q36003071-6D97A589-068E-44D5-8C33-0E28E0E40FDB

Q36003071-BE546607-9E3C-4F39-A5E9-315363EC0ADB

Q36003071-CCA7ED45-D8E9-4C50-9E03-ADAF015C9654

P577

Q36003071-63202DAF-6D1D-4577-B524-44AB8E0331EC

P5875

Q36003071-2C0DDCBE-E716-48CB-8156-7DB33DF10309

P698

Q36003071-116B71A6-6CDC-4B47-A5CB-6B96AD9A5416

P932

Q36003071-71DCAB70-6084-4A91-A671-6F1B7763687C

P356

P1433

Journal of the American Society of Nephrology

P1476

Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies

@en

P2093

Alexander Dressel

http://www.w3.org/2001/XMLSchema#string

Andreas Tomaschitz

http://www.w3.org/2001/XMLSchema#string

Bernhard K Krämer

http://www.w3.org/2001/XMLSchema#string

Christiane Drechsler

http://www.w3.org/2001/XMLSchema#string

Christoph Wanner

http://www.w3.org/2001/XMLSchema#string

Christoph Willmes

http://www.w3.org/2001/XMLSchema#string

Eberhard Ritz

http://www.w3.org/2001/XMLSchema#string

Graciela Delgado

http://www.w3.org/2001/XMLSchema#string

Katja Blouin

http://www.w3.org/2001/XMLSchema#string

Pim van der Harst

http://www.w3.org/2001/XMLSchema#string

P2860

Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis

Galectins: structure, function and therapeutic potential

Up-regulation of galectin-3 in acute renal failure of the rat

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.

Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury

Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.

Galectins as modulators of tumour progression.

Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis.

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction.

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.

P304

2213-2221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2014010093

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Pim van der Harst

Marcus E Kleber

Wiek H van Gilst

P577

2015-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270584604

http://www.w3.org/2001/XMLSchema#string

P698

25568176

http://www.w3.org/2001/XMLSchema#string

P932

4552104

http://www.w3.org/2001/XMLSchema#string